European Journal of Cancer
Volume 46, Issue 6 , Pages 1101-1110 , April 2010

Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: A population-based study in the Netherlands

  • A.E. Dassen

      Affiliations

    • Jeroen Bosch Hospital, Department of Surgery, P.O. Box 90153, 5200 ME’s-Hertogenbosch, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel.: +31 736992001; fax: +31 736992163.
    • ,
  • V.E.P.P. Lemmens

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Centre South (IKZ), P.O. Box 231, 5600 AE Eindhoven, The Netherlands
    • Erasmus MC University Medical Center, Department of Public Health, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
    • ,
  • L.V. van de Poll-Franse

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Centre South (IKZ), P.O. Box 231, 5600 AE Eindhoven, The Netherlands
    • Tilburg University, CoRPS, Department of Medical Psychology, P.O. Box 90153, 5000 LE Tilburg, The Netherlands
    • ,
  • G.J. Creemers

      Affiliations

    • Catharina Hospital, Department of Oncology, P.O. Box 1350, 5602 ZA Eindhoven, The Netherlands
    • ,
  • S.J. Brenninkmeijer

      Affiliations

    • TweeSteden Hospital, Department of Surgery, P.O. Box 90107, 5000 LA Tilburg, The Netherlands
    • ,
  • D.J. Lips

      Affiliations

    • Jeroen Bosch Hospital, Department of Surgery, P.O. Box 90153, 5200 ME’s-Hertogenbosch, The Netherlands
    • ,
  • A.A.M. vd Wurff

      Affiliations

    • St. Elisabeth Hospital, Department of Oncology, P.O. Box 90151, 5022 GC Tilburg, The Netherlands
    • ,
  • K. Bosscha

      Affiliations

    • Jeroen Bosch Hospital, Department of Surgery, P.O. Box 90153, 5200 ME’s-Hertogenbosch, The Netherlands
    • ,
  • J.W.W. Coebergh

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Centre South (IKZ), P.O. Box 231, 5600 AE Eindhoven, The Netherlands
    • Erasmus MC University Medical Center, Department of Public Health, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands

Received 20 December 2009 ,Revised 30 January 2010 ,Accepted 9 February 2010.

References 

  1. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581–592
  2. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009;45(6):931–991
  3. Karim-Kos HE, de Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345–1389
  4. Pinheiro PS, van der Heijden LH, Coebergh JW. Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: result of differential trends in incidence according to Lauren type and subsite. Int J Cancer. 1999;84(1):28–32
  5. Kaneko S, Yoshimura T. Time trend analysis of gastric cancer incidence in Japan by histological types, 1975–1989. Br J Cancer. 2001;84(3):400–405
  6. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79(9-10):1522–1530
  7. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345(8952):745–748
  8. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;45(10):725–730
  9. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20
  10. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol. 1993;22(3):369–376
  11. Louwman WJ, van de Poll-Franse LV, Fracheboud J, Roukema JA, Coebergh JW. Impact of a programme of mass mammography screening for breast cancer on socio-economic variation in survival: a population-based study. Breast Cancer Res Treat. 2007;105(3):369–375
  12. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol. 2005;55(3):231–240
  13. Koppert LB, Janssen-Heijnen ML, Louwman MW, et al. Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study. Eur J Gastroenterol Hepatol. 2004;16(7):681–688
  14. Percy C, Fritz A, Jack A, et al. International Classification of Diseases for Oncology (ICD-O). 3rd ed.. World Health Organization (WHO); 2000;
  15. Lambert R, Guilloux A, Oshima A, et al. Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer. 2002;97(6):811–818
  16. Cunningham SC, Kamangar F, Kim MP, et al. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg. 2005;9(5):718–725
  17. Hassan HA, Sharma VK, Raufman JP. Changing trends in gastric carcinoma at a university medical center: a twelve-year retrospective analysis. J Clin Gastroenterol. 2001;32(1):37–40
  18. Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut. 2007;56(7):918–925
  19. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–789
  20. Merry AH, Schouten LJ, Goldbohm RA, van den Brandt PA. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut. 2007;56(11):1503–1511
  21. van Blankenstein M, Looman CW, Siersema PD, Kuipers EJ, Coebergh JW. Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989–2003. Br J Cancer. 2007;96(11):1767–1771
  22. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29(4):645–654
  23. Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol. 2002;14(2):115–122
  24. Saito H, Fukumoto Y, Osaki T, et al. Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg. 2006;30(10):1864–1869
  25. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49
  26. Henson DE, Dittus C, Younes M, Nguyen H, bores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128(7):765–770
  27. Adachi Y, Yasuda K, Inomata M, et al. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer. 2000;89(7):1418–1424
  28. Macdonald JS, Smalley SR, Benedetti J. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: update of the results of intergroup Study fINT-0116 (SWOG 9008). 2004.
  29. <http://www.oncoline.nl>; 2008.
  30. Faivre J, Forman D, Esteve J, Gatta G. Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer. 1998;34(14):2167–2175
  31. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88(4):921–932
  32. Maruyama K, Kaminishi M, Hayashi K, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric cancer. 2006;9(2):51–66
  33. Verdecchia A, Corazziari I, Gatta G, et al. Explaining gastric cancer survival differences among European countries. Int J Cancer. 2004;109(5):737–741
  34. Costa ML, de Cassia Braga RK, Machado MA, Costa AC, Montagnini AL. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors. Ann Surg Oncol. 2006;13(6):843–850

PII: S0959-8049(10)00116-4

doi: 10.1016/j.ejca.2010.02.013

European Journal of Cancer
Volume 46, Issue 6 , Pages 1101-1110 , April 2010

Article Tools

* Image Usage & Resolution